An Integrated Self Management Programme to Improve Outcomes in Patients With Hand Osteoarthritis

Launched by DR IRIS TANG YAN KI · Feb 14, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new self-management program designed to help people with hand osteoarthritis (OA), a condition that causes pain and stiffness in the hands. The goal is to see if this program can improve pain and other symptoms better than standard medical care. In the trial, participants will be randomly divided into two groups: one group will start the self-management program right away, while the other will receive routine care for 26 weeks before starting the same program.

To participate in this study, you need to meet certain criteria. You should have a diagnosis of hand osteoarthritis and experience significant pain, rated at 40 or higher on a scale of 0 to 100. However, if you have other types of arthritis or are taking certain medications, you may not be eligible. Participants who join the trial will receive support from occupational therapists and rheumatology nurses over eight weeks, which will include learning how to manage their condition better. The trial aims to find out if this self-management approach can lead to less pain after 26 weeks compared to those receiving only routine care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Fulfil the American College of Rheumatology hand osteoarthritis classification criteria
• • Symptomatic hand osteoarthritis with a pain visual analogue score (VAS) equal to or more than 40/100mm within 2 weeks of study entry
• Exclusion Criteria:
• • Secondary hand osteoarthritis from inflammatory arthritis including rheumatoid arthritis, spondyloarthropathy, psoriatic arthritis, gouty arthropathy or connective tissue diseases;
• • Receive systemic corticosteroids (other than topical or inhalational) within 6 months of study entry
• • Inability to sign informed consent